Reading Time: < 1 minuteChimeric antigen receptor (CAR) T-cell treatment is a promising immunotherapy for multiple hematological cancers, especially for patients who have exhausted other treatment options. While CAR-T therapy represents hope for these patients, it can come with serious and life-threatening side effects. Cytokine Release Syndrome (CRS)—sometimes called a cytokine storm—is one of the most common CAR-T cell […]
Article




